Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia

Author:

Sahay Smita1ORCID,Devine Emily A.2,McCullumsmith Robert E.13,O’Donovan Sinead M.1ORCID

Affiliation:

1. Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA

2. Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA

3. Neuroscience Institute Promedica, Toledo, OH 43606, USA

Abstract

Schizophrenia is a devastating neuropsychiatric disorder associated with the dysregulation of glutamate and dopamine neurotransmitter systems. The adenosine system is an important neuroregulatory system in the brain that modulates glutamate and dopamine signaling via the ubiquitously expressed adenosine receptors; however, adenosine A1 and A2A receptor (A1R and A2AR) mRNA expression is poorly understood in specific cell subtypes in the frontal cortical brain regions implicated in this disorder. In this study, we assayed A1R and A2AR mRNA expression via qPCR in enriched populations of pyramidal neurons, which were isolated from postmortem anterior cingulate cortex (ACC) tissue from schizophrenia (n = 20) and control (n = 20) subjects using laser microdissection (LMD). A1R expression was significantly increased in female schizophrenia subjects compared to female control subjects (t(13) = −4.008, p = 0.001). A1R expression was also significantly decreased in female control subjects compared to male control subjects, suggesting sex differences in basal A1R expression (t(17) = 2.137, p = 0.047). A significant, positive association was found between dementia severity (clinical dementia rating (CDR) scores) and A2AR mRNA expression (Spearman’s r = 0.424, p = 0.009). A2AR mRNA expression was significantly increased in unmedicated schizophrenia subjects, suggesting that A2AR expression may be normalized by chronic antipsychotic treatment (F(1,14) = 9.259, p = 0.009). Together, these results provide novel insights into the neuronal expression of adenosine receptors in the ACC in schizophrenia and suggest that receptor expression changes may be sex-dependent and associated with cognitive decline in these subjects.

Funder

National Institute of Mental Health

American Foundation of Suicide Prevention

Publisher

MDPI AG

Subject

General Medicine

Reference101 articles.

1. Schizophrenia;Freedman;N. Engl. J. Med.,2003

2. Defects in Bioenergetic Coupling in Schizophrenia;Sullivan;Biol. Psychiatry,2018

3. Increased Brain Dopamine and Dopamine Receptors in Schizophrenia;Mackay;Arch. Gen. Psychiatry,1982

4. Psychosis pathways converge via D2High dopamine receptors;Seeman;Synapse,2006

5. Targeting the dopamine D2receptor in schizophrenia;Seeman;Expert Opin. Ther. Targets,2006

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View;International Journal of Molecular Sciences;2024-07-29

2. Microbiome and Long-Term Health Considerations;Obstetrics and Gynecology;2024-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3